These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 18186850

  • 1. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T, Chan JJ.
    Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
    [Abstract] [Full Text] [Related]

  • 2. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E.
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M.
    J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
    [Abstract] [Full Text] [Related]

  • 4. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
    van der Meij N, Keur I, van Lienden KP, Scheepstra CG, Bos JD.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2898-903. PubMed ID: 18257437
    [Abstract] [Full Text] [Related]

  • 5. Nephrogenic systemic fibrosis: an overview.
    Cowper SE.
    J Am Coll Radiol; 2008 Jan 29; 5(1):23-8. PubMed ID: 18180005
    [Abstract] [Full Text] [Related]

  • 6. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS, Sanyal S, Abraham JL.
    J Am Acad Dermatol; 2010 Feb 29; 62(2):337-42. PubMed ID: 19939504
    [Abstract] [Full Text] [Related]

  • 7. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
    Parsons AC, Yosipovitch G, Sheehan DJ, Sangüeza OP, Greenberg CS, Sane DC.
    Am J Dermatopathol; 2007 Oct 29; 29(5):433-6. PubMed ID: 17890909
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov 29; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
    Foss C, Smith JK, Ortiz L, Hanevold C, Davis L.
    Pediatr Dermatol; 2009 Nov 29; 26(5):579-82. PubMed ID: 19840315
    [Abstract] [Full Text] [Related]

  • 10. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.
    Am J Dermatopathol; 2009 Oct 29; 31(7):674-81. PubMed ID: 19633532
    [Abstract] [Full Text] [Related]

  • 11. Clinical and histological findings in nephrogenic systemic fibrosis.
    Cowper SE, Rabach M, Girardi M.
    Eur J Radiol; 2008 May 29; 66(2):191-9. PubMed ID: 18325705
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK, Garrett AL.
    Cutis; 2008 May 29; 81(5):421-6. PubMed ID: 18543594
    [Abstract] [Full Text] [Related]

  • 13. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.
    Clin Exp Dermatol; 2007 Jul 29; 32(4):353-8. PubMed ID: 17433041
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation.
    Edgar E, Woltjer R, Whitham R, Gultekin SH, Watnick S, Cupler EJ.
    Neuromuscul Disord; 2010 Jun 29; 20(6):411-3. PubMed ID: 20462761
    [Abstract] [Full Text] [Related]

  • 15. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Jun 29; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 16. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient.
    Anavekar NS, Chong AH, Norris R, Dowling J, Goodman D.
    Australas J Dermatol; 2008 Feb 01; 49(1):44-7. PubMed ID: 18186849
    [Abstract] [Full Text] [Related]

  • 18. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
    Shenoy C.
    Am J Med; 2008 Jan 01; 121(1):e11; author reply e13. PubMed ID: 18187056
    [No Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis: a report of 29 cases.
    Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, Mukherji SK, Swartz RD.
    AJR Am J Roentgenol; 2008 Mar 01; 190(3):736-41. PubMed ID: 18287446
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun 01; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.